Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,177 | -9,051 | -27,120 | -20,505 | -46,510 |
| Accounts payable and accrued liabilities | 57 | -180 | N/A | 319 | N/A |
| Other Working Capital | 544 | 296 | 40 | 284 | 620 |
| Other Operating Activity | 652 | 508 | 1,080 | 443 | 27,040 |
| Operating Cash Flow | $-19,924 | $-8,427 | $-26,000 | $-19,459 | $-18,850 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 14,860 | 14,863 | 41,230 |
| Financing Cash Flow | $N/A | $N/A | $14,860 | $14,863 | $41,230 |
| Beginning Cash Position | 24,864 | 24,864 | 36,000 | 36,004 | 13,620 |
| End Cash Position | 4,939 | 16,437 | 24,860 | 31,408 | 36,000 |
| Net Cash Flow | $-19,924 | $-8,427 | $-11,140 | $-4,596 | $22,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,924 | -8,427 | -26,000 | -19,459 | -18,850 |
| Free Cash Flow | -19,924 | -8,427 | -26,000 | -19,459 | -18,850 |